{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T10:53:21Z","timestamp":1762340001307},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2005,6,6]],"date-time":"2005-06-06T00:00:00Z","timestamp":1118016000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2005,6,6]],"date-time":"2005-06-06T00:00:00Z","timestamp":1118016000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2005,8,1]]},"DOI":"10.1038\/sj.bmt.1705036","type":"journal-article","created":{"date-parts":[[2005,6,6]],"date-time":"2005-06-06T09:10:18Z","timestamp":1118049018000},"page":"271-273","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Reduced intensity conditioning and allogeneic stem cell transplantation after salvage therapy integrating alemtuzumab for patients with relapsed peripheral T-cell non-Hodgkin's lymphoma"],"prefix":"10.1038","volume":"36","author":[{"given":"G G","family":"Wulf","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Hasenkamp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B","family":"Chapuy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Truemper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B","family":"Glass","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,6,6]]},"reference":[{"key":"BF1705036_CR1","first-page":"76","volume":"92","author":"C Gisselbrecht","year":"1998","unstructured":"Gisselbrecht C, Gaulard P, Lepage E et al. Prognostic significance of T-cell phenotype in aggressive non-Hodgkin's lymphomas. Blood 1998; 92: 76\u201382.","journal-title":"Blood"},{"key":"BF1705036_CR2","first-page":"1927","volume":"92","author":"B Coiffier","year":"1998","unstructured":"Coiffier B, Haioun C, Ketterer N et al. Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: a multicenter phase II study. Blood 1998; 92: 1927\u20131932.","journal-title":"Blood"},{"key":"BF1705036_CR3","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1056\/NEJMoa011795","volume":"346","author":"B Coiffier","year":"2002","unstructured":"Coiffier B, Lepage E, Briere J et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 2002; 346: 235\u2013242.","journal-title":"N Engl J Med"},{"key":"BF1705036_CR4","doi-asserted-by":"publisher","first-page":"2920","DOI":"10.1182\/blood-2003-10-3389","volume":"103","author":"G Enblad","year":"2004","unstructured":"Enblad G, Hagberg H, Erlanson M et al. A pilot study of alemtuzumab (anti-CD52 monoclonal antibody) therapy for patients with relapsed or chemotherapy-refractory peripheral T-cell lymphomas. Blood 2004; 103: 2920\u20132924.","journal-title":"Blood"},{"key":"BF1705036_CR5","first-page":"1272","volume":"88","author":"J Schetelig","year":"2003","unstructured":"Schetelig J, Fetscher S, Reichle A et al. Long-term disease-free survival in patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation. Haematologica 2003; 88: 1272\u20131278.","journal-title":"Haematologica"},{"key":"BF1705036_CR6","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1038\/sj.bmt.1702392","volume":"25","author":"A Nagler","year":"2000","unstructured":"Nagler A, Slavin S, Varadi G et al. Allogeneic peripheral blood stem cell transplantation using a fludarabine-based low intensity conditioning regimen for malignant lymphoma. Bone Marrow Transplantation 2000; 25: 1021\u20131028.","journal-title":"Bone Marrow Transplantation"},{"key":"BF1705036_CR7","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1083-8791(03)70005-6","volume":"9","author":"MR Bishop","year":"2003","unstructured":"Bishop MR, Hou JWS, Wilson WH et al. Establishment of early donor engraftment after reduced-intensity allogeneic hematopoietic stem cell transplantation to potentiate the graft-versus-lymphoma effect against refractory lymphomas. Biol Blood Marrow Transplant 2003; 9: 162\u2013169.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BF1705036_CR8","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/sj.bmt.1704600","volume":"34","author":"B Glass","year":"2004","unstructured":"Glass B, Nickelsen M, Dreger P et al. Reduced-intensity conditioning prior to allogeneic transplantation of hematopoietic stem cells: the need for T cells early after transplantation to induce a graft-versus-lymphoma effect. Bone Marrow Transplantation. 2004; 34: 391\u2013397.","journal-title":"Bone Marrow Transplantation."},{"key":"BF1705036_CR9","doi-asserted-by":"publisher","first-page":"3776","DOI":"10.1200\/JCO.1999.17.12.3776","volume":"17","author":"CH Moskowitz","year":"1999","unstructured":"Moskowitz CH, Bertino JR, Glassman JR et al. Ifosfamide, carboplatin, and etoposide: a highly effective cytoreduction and peripheral-blood progenitor-cell mobilization regimen for transplant-eligible patients with non-Hodgkin's lymphoma. J Clin Oncol 1999; 17: 3776\u20133785.","journal-title":"J Clin Oncol"},{"key":"BF1705036_CR10","first-page":"162","volume":"24","author":"E Weidmann","year":"2001","unstructured":"Weidmann E, Boehrer S, Chow KU et al. Treatment of aggressive, or progressing indolent peripheral T- and NK-cell neoplasias by combination of fludarabine, cyclophosphamide and doxorubicine. Onkologie 2001; 24: 162\u2013164.","journal-title":"Onkologie"},{"key":"BF1705036_CR11","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1182\/blood.V98.6.1721","volume":"98","author":"CE Dearden","year":"2001","unstructured":"Dearden CE, Matutes E, Cazin B et al. High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1\u2009H. Blood 2001; 98: 1721\u20131726.","journal-title":"Blood"},{"key":"BF1705036_CR12","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1080\/10428190310001609924","volume":"45","author":"A Chanan-Khan","year":"2004","unstructured":"Chanan-Khan A, Islam T, Alam A et al. Long-term survival with allogeneic stem cell transplant and donor lymphocyte infusion following salvage therapy with Anti-CD52 monoclonal antibody (Campath) in a patient with alpha\/beta hepatosplenic T-cell non-Hodgkin's lymphoma. Leuk Lymph 2004; 45: 1673\u20131675.","journal-title":"Leuk Lymph"},{"key":"BF1705036_CR13","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.1200\/JCO.2004.12.050","volume":"22","author":"P Corradini","year":"2004","unstructured":"Corradini P, Dodero A, Zallio F et al. Graft-versus-lymphoma effect in relapsed peripheral T-cell non-Hodgkin's lymphomas after reduced-intensity conditioning followed by allogeneic transplantation of hematopoietic cells. J Clin Oncol 2004; 22: 2172\u20132176.","journal-title":"J Clin Oncol"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1705036","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1705036.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1705036.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T00:36:29Z","timestamp":1648082189000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1705036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6,6]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,8,1]]}},"alternative-id":["BF1705036"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1705036","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,6,6]]},"assertion":[{"value":"6 June 2005","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}